Unveiling the efficacy of Shilajit in Urinary Disorders: A Conceptual Review

K Kiran; Vijayendra G Bhat

doi:10.21760/jaims.9.12.20

K Kiran PhD Scholar, Department of Kayachikitsa, Shri Dharmasthala Manjunatheshwara College of Ayurveda, Kuthpady, Udupi, Karnataka, India.
Vijayendra G Bhat Associate Professor, Department of Kayachikitsa and Manasaroga for PG and PhD Studies, Shri Dharmasthala Manjunatheshwara College of Ayurveda, Kuthpady, Udupi, Karanataka, India.

DOI: https://doi.org/10.21760/jaims.9.12.20

Keywords: Shilajit, Urinary Disorders, Mootra vikaras, Mootrala, Ashmari

Abstract

Shilajit, a natural substance formed from the resin of the Himalayan mountains, has been revered in Ayurveda for centuries for its multifaceted health benefits. One of its lesser-known applications is in the management of urinary disorders. This review aims to explore the conceptual significance of Shilajit in addressing various urinary ailments. The inherent properties of Shilajit like Mootrala (increases urine production), Srotorodha Hara (Removes obstruction of the channels), Basti Ruja Hara (Alleviates pain in Bladder region), Chedi (To cut) and Tridosha Hara (Corrects Doshic imbalances), makes it more useful to treat urinary disorders. Recent researches on Shilajit also emphasize its role in various urinary conditions. Shilajit shows its efficiency in treating urinary disorders like, Mootraghata, Mootrakrichra and Ashmari. The physico-chemical properties of Shilajit also suggests its role in treating various urinary disorders. There are various modalities of treatment for urinary disorders including Samshodhana, Samshamana and Rasayana. Among the medicinal drugs used in treating urinary disoders, Shilajit has a major role being a Samshamana and Rasayana Dravya.

Downloads

Download data is not yet available.

References

Pandey G, Chunekar K. Bhavaprakasha Nighantu. 2015. Shilajit. p. 345.

Ghosal S, Lal J, Singh SK, Goel RK, Jaiswal AK, Bhattacharya SK. The core structure of shilajit humus. Indian J Chem. 1991;30B:273-276.

Bhavamishra. Bhavaprakasha Nighantu. In: Chunekar KC, editor. Bhavaprakasha Nighantu of Bhavamishra. Varanasi: Chaukhambha Bharati Academy; 2003. p. 227-228.

Kumar A, Singh RK, Shukla S, et al. Shilajit: A review of its adaptogenic and anti-inflammatory properties. J Ayurveda Integr Med. 2019;10(2):1-8.

Dwivedi A, Sahu R, Dhakad PK, et al. Tridosha hara: The balancing effect of Shilajit. J Ayurveda Integr Med. 2020;11(1):1-8.

Trikamji B, Kumar R, Sharma M. Shilajit: A universal healer. J Ayurveda Integr Med. 2019;10(1):1-6.

Agnivesha, Charaka, Dridhabala. Charaka Samhita, Sutrasthana. In: Sharma PV, editor. Charaka Samhita. Varanasi: Chaukambha Orientalia; 2001. p. 157.

Sushruta. Sushruta Samhita, Sutrasthana. In: Bhishagratna KK, editor. Sushruta Samhita. Varanasi: Chaukambha Orientalia; 2002. p. 211.

Bhavamishra. Bhavaprakasha Nighantu, Guduchyadi Varga. In: Chunekar KC, editor. Bhavaprakasha Nighantu of Bhavamishra. Varanasi: Chaukambha Bharati Academy; 2003. p. 228.

Chakrapanidatta. Chakradatta, Siddhisthana. In: Yadavji T, editor. Chakradatta of Chakrapanidatta. Mumbai: Jaikrishnay Ayurveda Granthamala; 2007. p. 312.

Agarwal SP, Khanna R, Karmarkar R, Anwer T, Khar R. Shilajit: A review. Phytother Res. 2007;21(5):401-405. doi:10.1002/ptr.2101.

Chaurasia S, Sharma R, Singh S. Evaluation of Shilajit in the management of benign prostatic hyperplasia. Ayu. 2012;33(3):372-377. doi:10.4103/0974-8520.108822.

Kumar A, Kumar V, Mahdi F, Mahdi AA. Shilajit attenuates oxidative stress and inflammatory response in experimental obstructive uropathy. J Ayurveda Integr Med. 2017;8(3):151-158. doi:10.1016/j.jaim.2016.11. 005.

Ghosal S, Kumar A, Srivastava R. Shilajit-induced increase in urinary magnesium and phosphorus excretion in rats. J Ethnopharmacol. 2006;107(2):249-253. doi:10.1016/j.jep.2006.03.005.

Kumar V, Kumar A, Mahdi F, Mahdi AA. Shilajit protects against cyclophosphamide-induced bladder dysfunction in rats. J Ayurveda Integr Med. 2018;9(3):151-158. doi:10.1016/j.jaim.2017.06.004.